Prioritizing teachers in Covid vaccine distribution will continue to be a challenge until more doses are readily available, Andy Slavitt, senior advisor to the White House Covid-19 Response Team, said Wednesday. President Joe Biden has made reopening the nation’s schools for in-person instruction one of his top priorities. On Friday the Centers for Disease Control and Prevention… Read More »
“Those who are vaccine hesitant have had their hesitancy enhanced by a variety of things that are happening right now, particularly the unfortunate mix of science and politics,” Collins said at an event hosted by the National Academies of Sciences, Engineering and Medicine. A recent poll from the Kaiser Family Foundation found that more than… Read More »
Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of October—and that an FDA application could soon follow. But more than 60 researchers and bioethicists urged the partners to wait for more safety data before submitting their shot for a green light, Bloomberg reports. The experts called on… Read More »
It’s not just doctors, public health experts and scientists who are struggling to figure out how much of a threat the novel coronavirus poses. Like SARS and the pandemic flu before it, the newly emerged infection is presenting some unique challenges to Canada’s life insurance industry — and patients who might want to buy a… Read More »